Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Joel Carlos Lastoria"'
Autor:
Melissa de Almeida Corrêa Alfredo, Juliano Vilaverde Schmitt, Anna Carolina Miola, Simone de Pádua Milagres, Joel Carlos Lastoria
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 99, Iss 1, Pp 53-56 (2024)
Abstract Background: Thalidomide is the drug of choice for the treatment of type 2 leprosy reactions and is often associated with corticosteroids. The use of these drugs in multiple myeloma is associated with the risk of cardiovascular events, but th
Externí odkaz:
https://doaj.org/article/96a78ff7ba9a43bcbab9bcfce8974a02
Autor:
Cintia Santos Braghiroli, Maria Rita Parise-Fortes, Mariângela Esther Alencar Marques, Joel Carlos Lastória
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 94, Iss 5, Pp 586-589 (2019)
Abstract Cutaneous neoplasms frequently occur in leprosy, but there are few reports of the coexistence of leprosy and basal cell carcinoma in the same lesion. This case reports a 49-year-old male with an ulcerated plaque on the right lateral nasal wa
Externí odkaz:
https://doaj.org/article/aec32c327faf4942a01368069d0e33ce
Autor:
Joel Carlos Lastória, Thaís Sampaio Corrêa de Almeida, Maria Stella de Mello Ayres Putinatti, Carlos Roberto Padovani
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 93, Iss 2, Pp 181-184 (2018)
Abstract: Background: Erythema nodosum leprosum may appear before, during or after treatment of leprosy and is one of the main factors for nerve damage in patients. When it occurs or continues to occur after treatment, it may indicate disease recurre
Externí odkaz:
https://doaj.org/article/1a2c572e390b4b20988996dfa50f89e6
Autor:
Lucia Helena Soares Camargo Marciano, Andréa de Faria Fernandes Belone, Patrícia Sammarco Rosa, Neusa Maria Broch Coelho, Cássio César Ghidella, Susilene Maria Tonelli Nardi, William Cabral Miranda, Ligia Vizeu Barrozo, Joel Carlos Lastória
Publikováno v:
Cadernos de Saúde Pública, Vol 34, Iss 8 (2018)
Abstract: This study aimed to identify the distribution pattern of leprosy in a hyperendemic municipality in Brazil and determine its relationship with the clinico-epidemiological situation over 11 years. The geographic information system, MapInfo, s
Externí odkaz:
https://doaj.org/article/82bc8852daed48b281acc1dc2c4f0f5e
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 91, Iss 3, Pp 393-395 (2016)
Abstract: The Brazilian Society of Dermatology promoted a national campaign against leprosy in 2012, involving their State Regional, Accredited Services of Dermatology and Referral Services in Leprosy. Consisted of clarification to the population abo
Externí odkaz:
https://doaj.org/article/7c2c4b1106004e009a264b93674ebebe
Autor:
Silvio Alencar Marques, Joel Carlos Lastória, Rosangela Maria Pires de Camargo, Mariangela Esther Alencar Marques
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 91, Iss 3, Pp 384-386 (2016)
Abstract: The authors report aspects of paracoccidioidomycosis, acute-subacute clinical form, juvenile type, in a 19-year-old female patient. Paracoccidioidomycosis, juvenile type, classically occurs in young patients, both sexes, with lymphoma-like
Externí odkaz:
https://doaj.org/article/1e156bb1cdfc430c9bf3877d1dea0404
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 89, Iss 3, Pp 389-401 (2014)
Leprosy is a chronic infectious condition caused by Mycobacterium leprae(M. leprae). It is endemic in many regions of the world and a public health problem in Brazil. Additionally, it presents a wide spectrum of clinical manifestations, which are dep
Externí odkaz:
https://doaj.org/article/713218cef09e49b6854c66e30fb0b981
Autor:
Vidal Haddad, Joel Carlos Lastória
Publikováno v:
Journal of Venomous Animals and Toxins including Tropical Diseases, Vol 20, Iss 0, Pp 16-20 (2014)
Externí odkaz:
https://doaj.org/article/2a4532c0d5f349ab8e617a0cb69ab78d
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 89, Iss 2, Pp 205-218 (2014)
Leprosy is caused by Mycobacterium leprae and has been known since biblical times. It is still endemic in many regions of the world and a public health problem in Brazil. The prevalence rate in 2011 reached 1.54 cases per 10,000 inhabitants in Brazil
Externí odkaz:
https://doaj.org/article/96b45f7012b34ab6a07facf2355c030f
Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 89, Iss 2, Pp 266-272 (2014)
BACKGROUND: Leprosy can have its course interrupted by type 1 and 2 reactional episodes, the last named of erythema nodosum leprosum (ENL). Thalidomide has been the medication of choice for the control of ENL episodes since 1965. OBJECTIVES: These ep
Externí odkaz:
https://doaj.org/article/7679d0113d5241ceaede190010fc01c5